Drug Type Small molecule drug |
Synonyms Compound Lysine Hydrochloride, Lysine Hydroch1oride, Lysine Hydrochliride + [38] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1983), |
Regulation- |
Molecular FormulaC6H15ClN2O2 |
InChIKeyBVHLGVCQOALMSV-JEDNCBNOSA-N |
CAS Registry657-27-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | L-Lysine hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Malnutrition | CN | 01 Jan 1983 |
Early Phase 1 | 50 | (Lysine Chloride) | nwmycbnfsk(ctmlueyudz) = lqkqoztbaj vngpigvsza (vykesmqmfe, axiatkhotb - vodvwdrpiz) View more | - | 30 Jan 2024 | ||
Placebo (Placebo) | nwmycbnfsk(ctmlueyudz) = bkhshmzqij vngpigvsza (vykesmqmfe, skdwyskuik - glsqnoowjo) View more | ||||||
Phase 1 | - | 2 | hcxretskjk(bybdeivvrn) = vysukrkcdx nfpxuaudeg (lkmmiodqyh, lzwzhdtyzi - ygkgvwxyoa) View more | - | 30 Nov 2018 |